[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:congenital-adrenal-hyperplasia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":43,"states":44},"Congenital Adrenal Hyperplasia",5,4,[8,16,23,30,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06712823","An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia",[12],"Phase 2","RECRUITING","2026-08-26T02:17:26.640202Z","2026-07-05T03:45:20.454869Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05669950","A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:34.622081Z","2026-05-05T02:43:27.805911Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07144163","A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia",[27],"Phase 3","2026-08-26T02:18:29.369233Z","2026-05-05T02:35:31.775874Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT00250159","Natural History Study of Patients With Excess Androgen",[],"2026-08-26T02:16:39.977107Z","2026-05-13T02:55:06.034012Z",{"nct_id":37,"title":38,"phases":39,"status":40,"updated_at":41,"content_modified":42},"NCT07611786","Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia",[],"NOT_YET_RECRUITING","2026-08-26T02:16:55.892527Z","2026-05-29T15:36:40.229538Z",[],[]]